-
Signature
-
/s/ W. Eric Marr, as Attorney-In-Fact for David J. Bonenberger
-
Issuer symbol
-
PPL
-
Transactions as of
-
20 Jan 2026
-
Net transactions value
-
+$128,142
-
Form type
-
4
-
Filing time
-
21 Jan 2026, 16:08:13 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Bonenberger David J |
EVP & COO-Utilities |
645 HAMILTON STREET, ALLENTOWN |
/s/ W. Eric Marr, as Attorney-In-Fact for David J. Bonenberger |
21 Jan 2026 |
0001913975 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PPL |
Common Stock |
Options Exercise |
$191,848 |
+5,198 |
+11% |
$36.91 |
50,901 |
20 Jan 2026 |
Direct |
F1 |
| transaction |
PPL |
Common Stock |
Tax liability |
$63,707 |
-1,726 |
-3.4% |
$36.91 |
49,175 |
20 Jan 2026 |
Direct |
F1, F2 |
| holding |
PPL |
Common Stock |
|
|
|
|
|
5,073 |
20 Jan 2026 |
Held in trust pursuant to the Employee Stock Ownership Plan. |
F1 |
| holding |
PPL |
Common Stock |
|
|
|
|
|
100 |
20 Jan 2026 |
By Spouse in IRA. |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PPL |
Stock Unit (SIP) |
Options Exercise |
$0 |
-5,198 |
-100% |
$0.000000 |
0 |
20 Jan 2026 |
Common Stock |
5,198 |
$0.000000 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: